MALIN R. DOLLINGER, M.D.; IRWIN H. KRAKOFF, M.D., F.A.C.P.; DAVID A. KARNOFSKY, M.D., F.A.C.P.
Quinacrine (Atabrine®) inhibited the growth of several transplanted solid tumors (1) and of the Ehrlich ascites tumor in mice (when it was given intraperitoneally) (2). It was cytotoxic to a variety of normal and tumor cells grown in tissue culture (3). In a variety of experimental tumors and in man cytotoxic levels comparable to those effective against tumor cells in tissue culture could not be achieved without unacceptable host toxicity. By local instillation into serous cavities, high local concentrations of quinacrine were obtained. When used clinically, it was found by Gellhorn, Zaidenweber, Ultmann, and Hirschberg (2) and by Ultmann, Gellhorn,
DOLLINGER MR, KRAKOFF IH, KARNOFSKY DA. Quinacrine (Atabrine®) in the Treatment of Neoplastic Effusions. Ann Intern Med. ;66:249–257. doi: 10.7326/0003-4819-66-2-249
Download citation file:
Published: Ann Intern Med. 1967;66(2):249-257.
Hospital Medicine, Pulmonary/Critical Care.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use